Researchers have identified antibodies that not only block infection with the latest variant of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), but are also effective against future coronaviruses. With the evolution of SARS-CoV-2, the efficacy of vaccines and antibodies is reduced in the laboratory. So how can a treatment be developed that resists virus […]